What's Happening?
Consumer Reports has issued a warning against the use of cold medicines containing phenylephrine, stating that research shows it is no more effective than a placebo for relieving nasal congestion. The
FDA has even proposed removing phenylephrine as an active ingredient from cold medicines. Instead, Consumer Reports suggests alternative remedies such as honey in hot tea, salt water gargling, and chicken soup to alleviate cold symptoms. Additionally, using a cool-mist humidifier to maintain indoor humidity between 30 and 50 percent can help relieve nasal congestion. For those opting for medication, pseudoephedrine is recommended, although it requires an ID for purchase. Nasal decongestant sprays like oxymetazoline should be used cautiously, as prolonged use can worsen congestion.
Why It's Important?
The advice from Consumer Reports is significant as it challenges the effectiveness of a common ingredient in over-the-counter cold medications, potentially impacting consumer choices and pharmaceutical sales. With the FDA considering regulatory changes, this could lead to a shift in the market for cold remedies. Consumers may need to seek alternative treatments, which could affect sales of products containing phenylephrine. The guidance also emphasizes the importance of effective symptom management during cold and flu season, which can influence public health outcomes by encouraging more effective self-care practices.
What's Next?
If the FDA proceeds with removing phenylephrine from cold medicines, manufacturers may need to reformulate their products, potentially leading to changes in the availability and marketing of cold remedies. Consumers might increasingly turn to alternative treatments or medications like pseudoephedrine, which could see a rise in demand. Additionally, public health messaging may focus more on non-pharmaceutical interventions for managing cold symptoms, promoting a shift in consumer behavior towards more natural remedies and preventive measures.
